Literature DB >> 21928138

Bicistronic vector for combined expression of the HSVtk killer gene and cytokine GM-CSF gene in cancer cells.

I V Alekseenko1, E P Kopantzev, T V Vinogradova, E D Sverdlov.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21928138     DOI： 10.1134/S1607672911040065

Source DB:  PubMed          Journal:  Dokl Biochem Biophys        ISSN： 1607-6729            Impact factor:   0.788


× No keyword cloud information.
  15 in total

1.  Bystander killing effect of tymidine kinase gene-transduced adult bone marrow stromal cells with ganciclovir on malignant glioma cells.

Authors:  Kentaro Mori; Junko Iwata; Masahiro Miyazaki; Hideo Osada; Yuichi Tange; Takuji Yamamoto; Yasuhisa Aiko; Masaru Tamura; Toshihiko Shiroishi
Journal:  Neurol Med Chir (Tokyo)       Date:  2010       Impact factor: 1.742

2.  Efficacy of herpes simplex virus thymidine kinase in combination with cytokine gene therapy in an experimental metastatic breast cancer model.

Authors:  A S Majumdar; A Zolotorev; S Samuel; K Tran; B Vertin; M Hall-Meier; B A Antoni; E Adeline; M Philip; R Philip
Journal:  Cancer Gene Ther       Date:  2000-07       Impact factor: 5.987

Review 3.  Antiviral activity and mechanism of action of ganciclovir.

Authors:  T Matthews; R Boehme
Journal:  Rev Infect Dis       Date:  1988 Jul-Aug

4.  Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity.

Authors:  G Dranoff; E Jaffee; A Lazenby; P Golumbek; H Levitsky; K Brose; V Jackson; H Hamada; D Pardoll; R C Mulligan
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

5.  The "bystander effect": tumor regression when a fraction of the tumor mass is genetically modified.

Authors:  S M Freeman; C N Abboud; K A Whartenby; C H Packman; D S Koeplin; F L Moolten; G N Abraham
Journal:  Cancer Res       Date:  1993-11-01       Impact factor: 12.701

6.  The encephalomyocarditis virus internal ribosome entry site allows efficient coexpression of two genes from a recombinant provirus in cultured cells and in embryos.

Authors:  I R Ghattas; J R Sanes; J E Majors
Journal:  Mol Cell Biol       Date:  1991-12       Impact factor: 4.272

7.  Suicide gene and cytokines combined nonviral gene therapy for spontaneous canine melanoma.

Authors:  L M E Finocchiaro; G L Fiszman; A L Karara; G C Glikin
Journal:  Cancer Gene Ther       Date:  2008-01-25       Impact factor: 5.987

8.  Functional significance of a putative sp1 transcription factor binding site in the survivin gene promoter.

Authors:  M V Mityaev; E P Kopantzev; A A Buzdin; T V Vinogradova; E D Sverdlov
Journal:  Biochemistry (Mosc)       Date:  2008-11       Impact factor: 2.487

9.  A novel combination of suicide gene therapy and histone deacetylase inhibitor for treatment of malignant melanoma.

Authors:  Seiji Yamamoto; Tomoki Yamano; Maki Tanaka; Dave S B Hoon; Sonshin Takao; Ryuichi Morishita; Takashi Aikou; Yasufumi Kaneda
Journal:  Cancer Gene Ther       Date:  2003-03       Impact factor: 5.987

10.  AAV2-mediated in vivo immune gene therapy of solid tumours.

Authors:  Sara A Collins; Alexandra Buhles; Martina F Scallan; Patrick T Harrison; Deirdre M O'Hanlon; Gerald C O'Sullivan; Mark Tangney
Journal:  Genet Vaccines Ther       Date:  2010-12-20
View more
  1 in total

1.  Therapeutic properties of a vector carrying the HSV thymidine kinase and GM-CSF genes and delivered as a complex with a cationic copolymer.

Authors:  Irina V Alekseenko; Eugene V Snezhkov; Igor P Chernov; Victor V Pleshkan; Victor K Potapov; Alexander V Sass; Galina S Monastyrskaya; Eugene P Kopantzev; Tatyana V Vinogradova; Yuri V Khramtsov; Alexey V Ulasov; Andrey A Rosenkranz; Alexander S Sobolev; Olga A Bezborodova; Anna D Plyutinskaya; Elena R Nemtsova; Raisa I Yakubovskaya; Eugene D Sverdlov
Journal:  J Transl Med       Date:  2015-03-04       Impact factor: 5.531
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.